This offer is set to expire
| |
Dear Reader,
I'm writing to let you know that the Stansberry Member Services team goes home for the night in just 30 minutes.
Until then, it's not too late to call us at 800-961-5843 to process your order for Stansberry Venture Technology.
At midnight tonight, Dave Lashmet's special offer expires.
But there's still a little time left to sign up. (You can do so online in just a few minutes, here.)
Remember: We're offering you a $500 discount to sign up in the next 30 minutes.
When you do, you'll receive:
Access to Dave's Special Report on how to buy the little-known company that could revolutionize cancer treatment and make you up to 500% gains on a single position.
Two years of access to Stansberry Venture Technology (normally $5,500/year)
A 1-year free trial to Dr. David Eifrig's Retirement Millionaire (normally $199/year)After midnight tonight – this offer expires. If you decide to join tomorrow, you'll need to pay an additional $500.
If you're interested, I urge you to place your order now.
Tonight could realistically be the lowest price you'll ever see.
Click here to join Stansberry Venture Technology before midnight, or call us at 800-961-5843 to process your discount over the phone.
Best,
Mike Cottet
Director of Member Services
Stansberry Research
P.S. I have a wife and kids; I need to go home to at midnight tonight. So if you have any questions about this offer, please call me now, before we turn off the phones at midnight. My team and I can answer any questions you may have about this offer.
You can ring us now at 800-961-5843. |
|
| |
All contents of this e-mail are copyright 2017 by Stansberry Research. All rights reserved. Reproducing any part of this document is prohibited without the express written consent of Porter Stansberry. Protected by U.S. Copyright Law {Title 17 U.S.C. Section 101 et seq., Title 18 U.S.C. Section 2319}: Infringements can be punishable by up to five years in prison and $250,000 in fines.
DISCLAIMER: The work included in this publication is based on SEC filings, current events, interviews, and corporate press releases. It may contain errors, and you shouldn't make any investment decision based solely on what you read here. It's your money and your responsibility. The views expressed in this publication do not necessarily reflect the views of Stansberry Research.
You're receiving this email at [email protected]. If you have any questions about your subscription, or would like to change your email settings, please contact Stansberry Research at (888) 261-2693 Monday-Friday between 9:00 a.m. and 5:00 p.m. Eastern Time. Or if calling internationally, please call 443-839-0986. Stansberry Research, 1125 N Charles Street Baltimore, MD 21201. If you wish to contact us by email, please do not reply to this message but instead go to [email protected].
To unsubscribe from this mailing, click here: Unsubscribe
|
|
|
